FDA Inspection 989403 — Conopco Inc. D/B/A Unilever

Conopco Inc. D/B/A Unilever — FEI 1047784

The FDA completed an inspection of Conopco Inc. D/B/A Unilever on Sep 16, 2016 in Raeford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 16, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Raeford, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
457621 CFR 211.192No written record of investigation